| scholarly article | Q13442814 |
| P50 | author | Johan van Griensven | Q28817139 |
| Raffaella Ravinetto | Q28817172 | ||
| Lut Lynen | Q42886337 | ||
| Malcolm G. Semple | Q45398929 | ||
| Peter G. Smith | Q47708456 | ||
| Anja De Weggheleire | Q55455280 | ||
| Tansy Edwards | Q91794833 | ||
| Maaike De Crop | Q114529794 | ||
| Elhadj Ibrahima Bah | Q114529798 | ||
| P2093 | author name string | Joris Menten | |
| Yves Claeys | |||
| Ebola_Tx Consortium | |||
| Sarah Temmerman | |||
| P2860 | cites work | The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis | Q27001157 |
| Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections | Q28248431 | ||
| Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study | Q33425160 | ||
| Doctors and vampires in sub-Saharan Africa: ethical challenges in clinical trial research | Q34015837 | ||
| The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field | Q34489055 | ||
| Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee | Q34492427 | ||
| Randomised controlled trials for Ebola: practical and ethical issues | Q35360159 | ||
| Evaluating large-scale blood transfusion therapy for the current Ebola epidemic in Liberia | Q35661932 | ||
| Passive antibody therapy for infectious diseases | Q35889582 | ||
| Statistical considerations for a trial of Ebola virus disease therapeutics | Q36620043 | ||
| Raising the standard for clinical care of patients with Ebola virus disease | Q40143313 | ||
| First Ebola treatment is approved by WHO. | Q44093419 | ||
| WHO meeting chooses untried interventions to defeat Ebola | Q44093632 | ||
| Blood as medicine: social meanings of blood and the success of Ebola trials | Q44096147 | ||
| Large-scale convalescent blood and plasma transfusion therapy for Ebola virus disease | Q44096329 | ||
| Ebola: better protection needed for Guinean health-care workers | Q44096777 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Ebola hemorrhagic fever | Q51993 |
| 2014 Ebola virus epidemic in Guinea | Q18160902 | ||
| Orthoebolavirus zairense | Q10538943 | ||
| convalescent plasma | Q105209484 | ||
| P304 | page(s) | 13-21 | |
| P577 | publication date | 2016-01-14 | |
| P1433 | published in | Clinical Trials | Q5133802 |
| P1476 | title | Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak | |
| P478 | volume | 13 |
| Q44104048 | Efficacy of Convalescent Plasma in Relation to Dose of Ebola Virus Antibodies |
| Q36305916 | Generation and characterization of protective antibodies to Marburg virus. |
| Q57092449 | Human Polyclonal Antibodies Produced by Transchromosomal Cattle Provide Partial Protection Against Lethal Zaire Ebolavirus Challenge in Rhesus Macaques |
| Q40091054 | Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates |
| Q57091968 | Performance of different clinical trial designs to evaluate treatments during an epidemic |
| Q47116619 | Protected to death: systematic exclusion of pregnant women from Ebola virus disease trials |
| Q64129697 | The Special Pathogens Research Network: Enabling Research Readiness |
| Q91024578 | Towards quantification of protective antibody responses by passive transfer of the 1st WHO International Standard for Ebola virus antibody in a guinea pig model |
| Q30238976 | Use of convalescent plasma in Ebola virus infection |
| Q57454623 | What motivates Ebola survivors to donate plasma during an emergency clinical trial? The case of Ebola-Tx in Guinea |
Search more.